ArticleCancer medicine2023

Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trial.

Alberto Hernando-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.